Texas Senate Bill SB339

Texas 2015 - 84th Regular

Caption

Relating to the medical use of low-THC cannabis and the regulation of related organizations and individuals; requiring a dispensing organization to obtain a license to dispense low-THC cannabis and any employee of a dispensing organization to obtain a registration; authorizing fees.

Impact

The bill significantly alters the legal landscape concerning the use of cannabis for medical purposes within Texas. By defining low-THC cannabis and establishing protocols for its prescription, the act creates a legal avenue for patients suffering from intractable epilepsy to access this form of treatment. Notably, it also prohibits local municipalities and counties from enacting regulations that would prevent the cultivation, processing, or dispensing of low-THC cannabis, thereby centralizing control at the state level.

Summary

SB339, also known as the Texas Compassionate-Use Act, establishes a framework for the medical use of low-THC cannabis in Texas. This legislation allows for licensed dispensing organizations to cultivate, process, and dispense low-THC cannabis to patients with specific medical conditions, particularly intractable epilepsy. It mandates that those organizations must be licensed by the Department of Public Safety (DPS), and their employees must register with the department, ensuring compliance and oversight in the cannabis distribution process.

Sentiment

The sentiment surrounding SB339 is generally positive among supporters who view it as a compassionate measure aiding patients with debilitating conditions. Advocates, including medical professionals and patient rights groups, support the move towards legalization for medicinal purposes. However, there has been some contention among opponents who argue against broader cannabis policies, fearing potential misuse or a slippery slope towards full legalization of recreational cannabis.

Contention

The notable points of contention focus on the restrictions placed on local governments and the regulations around who can prescribe low-THC cannabis. Critics worry that limiting local control undermines community choices, and they question the level of bureaucratic oversight required for physicians to prescribe this treatment. Additionally, while the bill is a significant step forward for medical cannabis, debates continue regarding further reforms that could expand access or adjust limitations imposed by the act.